聯(lián)系電話
翌圣生物科技（上海）股份有限公司
初級會員·13年您現(xiàn)在的位置： 翌圣生物科技（上海）股份有限公司>>蛋白與免疫>>重組蛋白>> 92274ES60Recombinant Human R-Spondin-1 Protein,His (Human R
92274ES60Recombinant Human R-Spondin-1 Protein,His (Human R
| 參考價(jià): | 面議 |
具體成交價(jià)以合同協(xié)議為準(zhǔn)- 92274ES60 產(chǎn)品型號
- Yeasen/翌圣生物 品牌
- 生產(chǎn)商 廠商性質(zhì)
- 上海市 所在地
訪問次數(shù)：319更新時(shí)間：2022-05-08 19:30:05
聯(lián)系我們時(shí)請說明是化工儀器網(wǎng)上看到的信息，謝謝!
- 聯(lián)系人：
- 曹女士
- 電話：
- 400-6111-883
- 手機(jī)：
- 售后：
- 4006-111-883
- 傳真：
- 86-21-34615995
- 地址：
- 上海市浦東新區(qū)天雄路166弄1號3樓
- 網(wǎng)址：
- www.yeasen.com
掃一掃訪問手機(jī)商鋪
產(chǎn)品簡介
| 供貨周期 | 現(xiàn)貨 | 規(guī)格 | 100ug |
|---|---|---|---|
| 貨號 | 92274ES60 | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,生物產(chǎn)業(yè) |
產(chǎn)品介紹
Product Information
Product Name
Cat#
Size
Price（￥）
Recombinant Human R-Spondin-1 Protein,His (Human RSPO1,His )
92274ES60
100 μg
5775.00
92274ES80
1 mg
31425.00
Product Description
R-Spondin 1 (RSPO1, Roof plate-specific Spondin 1), also known as cysteine-rich and single thrombospondin domain containing protein 3, is a 27 kDa secreted protein that shares ~40% aa identity with three other R-Spondin family members . All R-Spondins regulate Wnt/ beta-Catenin signaling but have distinct expression patterns. In humans, rare disruptions of the R-Spondin 1 gene are associated with tendencies for XX sex reversal (phenotypic male) or hermaphroditism, indicating a role for R-Spondin 1 in gender- Injection of recombinant R-Spondin 1 in mice causes activation of beta-catenin and proliferation of intestinal crypt epithelial cells, and ameliorates experimental colitis. Interest in R-Spondin 1 as a cell culture supplement has grown with the expansion of the organoid field. R-Spondin 1 is widely used in organoid cell culture workflows as a vital component that promotes both growth and survival of 3D organoids .
Product Properties
Synonyms
R-Spondin 1 ；Roof Plate-specific Spondin 1
Accession
Q2MKA7
Source
HEK293 Cells-derived human RSPO1 protein, Met1 22-Ala 263 with His tag at the C-terminus.
Molecular Weight
Approximately 28.2 kDa. As a result of glycosylation, RSPO1 migrates as an approximately 42 kDa band in SDS-PAGE under reducing conditions.
AA Sequence
MRLGLCVVAL VLSWTHLTIS SRGIKGKRQR RISAEGSQAC AKGCELCSEV NGCLKCSPKL FILLERNDIR QVGVCLPSCP PGYFDARNPD MNKCIKCKIE HCEACFSHNF CTKCKEGLYL HKGRCYPACP EGSSAANGTM ECSSPAQCEM SEWSPWGPCS KKCGFRR GSEERTRRVL HAPVGDHAAC SDTKETRRCT VRRVPCPEGQ KRRKGGQGRR ENANRNLARK ESKEAGAGSR RRKG QGTVGPLTSA GPA
Tag
His
Physical Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity
> 95% by SDS-PAGE.
Biological Activity
1. Measured by its ability to induce activation of ?-catenin response in a Topflash Luciferase assay using HEK293T human embryonic kidney cells. The ED50 for this effect is typically 0.1-0.9 μg/mL in the presence of 5 ng/mL recombinant mouse Wnt3a.
2. Measured by its binding ability in a functional ELISA. Immobilized human RSPO1 at 20 μg/ml (100 μl/well) can bind human LIMPII with a linear range of 32-800 ng/ml.
3. Measured by its binding ability in a functional ELISA. Immobilized human RSPO1 at 20 μg/ml (100 μl/well) can bind mouse CD36 with a linear range of 6.4-800 ng/ml.Endotoxin
< 1.0 EU per 1μg of the protein by the LAL method.
Formulation
Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4.
Reconstitution
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20°C. Further dilutions should be made in appropriate buffered solutions.
Shipping and Storage
The products are shipped with ice pack and can be stored at -20℃ to -80℃ for 1 year.
Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.
Cautions
1. Avoid repeated freeze-thaw cycles.
2. For your safety and health, please wear lab coats and disposable gloves for operation.
3. For research use only.
HB220413
